Published on
Last updated on
Cisema Webinar with CBBC: Opportunities and Regulatory Implications Associated with the Rise of China's Digital Economy in Healthcare
Cisema will jointly present a webinar session with the China-Britain Business Council on July 30 to provide an overview of the latest policies and market opportunities for digital healthcare in China.
The session will be interactive, and will go through many interesting topics:
- What are the key digital health trends in China?
- How does risk class classification for the NMPA (former CFDA) work?
- Are there any fast-track regulatory pathways?
- What are the latest updates regarding digital health regulations?
Date: July 30
Time: 09:30AM – 10:30AM
Price: Free of charge
Open for: CBBC members only
Our speakers:
Anna King
Business Consultant, Cisema
Hamish King
Director of Business Development, Cisema
Connect with Cisema
With more than 20 years of experience and a team of over 100 specialists, Cisema helps global companies achieve compliance across Asia Pacific with confidence and accelerate market entry.
Stay Informed with Monthly News and Analysis
Stay informed with the latest regulatory changes, expert insights, and market opportunities across APAC, delivered straight to your inbox.
Related News
China Expands MRI Registration Requirements Under New 2026 Review Guideline
Manufacturers seeking MRI registration in China must meet expanded technical, software, and validation requirements.
China CMDE Releases New Review Documents for Oncology NGS & HLA-B*58:01 Reagents
The new documents clarify expectations for Tier III variants, companion diagnostic clinical evaluation, tissue and plasma registration, and HLA-B*58:01 analytical validation.
Taiwan Extends Cosmetic GMP Requirements to Nearly All Manufacturing Sites
As of July 1, 2026, Taiwan has completed its cosmetic GMP rollout, extending mandatory ISO 22716-based manufacturing standards to nearly all cosmetic factories